Search
for
Sort by
Research 31–60 of 473
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin disorders associated with the COVID‐19 pandemic: A review
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Cutaneous manifestations of COVID-19
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Mucocutaneous manifestations in children with human immunodeficiency virus infection
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Abstract- Poster
- Management of Dermatologic Toxicities
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- A Case of Rhupus with Rowell Syndrome
- Dizziness and rash in an HIV positive man
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Severe and Fatal Phenobarbitone Eruptions
- Scaly Papular Lesions
- Fixed-Drug Eruption due to Dextromethorphan
- Drug eruptions in dermatology
- Cutaneous Reactions to Drugs
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Drug-Induced Skin, Nail and Hair Disorders
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Cutaneous drug reactions
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis